Showing results (1-10 of 415) with videos related to
Sort By:
Pageof 42
Plos One|April 12, 2007
The temperature-sensitive role of Cryptococcus neoformans ROM2 in cell morphogenesisBeth Burgwyn Fuchs, Robin J Tang, Eleftherios MylonakisEukaryotic Cell|September 1, 2009
Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathwaysBeth Burgwyn Fuchs, Eleftherios MylonakisCurrent Opinion in Microbiology|July 4, 2006
Using non-mammalian hosts to study fungal virulence and host defenseBeth Burgwyn Fuchs, Eleftherios MylonakisFrontiers in Microbiology|May 3, 2021
Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive BacteriaLewisOscar Felix, Eleftherios Mylonakis, Beth Burgwyn FuchsMethods in Molecular Biology (Clifton, N.J.)|March 26, 2014
Nonmammalian model systems to investigate fungal biofilmsMarios Arvanitis, Beth Burgwyn Fuchs, Eleftherios MylonakisFuture Microbiology|October 13, 2018
Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptionsBeth Burgwyn Fuchs, Nagendran Tharmalingam, Eleftherios MylonakisCurrent Pharmaceutical Design|April 8, 2011
Caenorhabditis elegans-based model systems for antifungal drug discoveryCleo G Anastassopoulou, Beth Burgwyn Fuchs, Eleftherios MylonakisFrontiers in Microbiology|August 6, 2019
The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant Staphylococcus aureusNagendran Tharmalingam, Rajamohammed Khader, Beth Burgwyn Fuchs, et al.Expert Opinion on Pharmacotherapy|February 4, 2021
Current and promising pharmacotherapeutic options for candidiasisLiliana Scorzoni, Beth Burgwyn Fuchs, Juliana Campos Junqueira, et al.Mycopathologia|October 6, 2010
Galleria mellonella are resistant to Pneumocystis murina infectionBeth Burgwyn Fuchs, Lisa R Bishop, Joseph A Kovacs, et al.Pageof 42